Cathie Wood's ETFs Sell Twist Bioscience Stock Amid Gains
Cathie Wood’s ARK Innovation ETF and Ark Genomic Revolution ETF sold $11.2 million worth of shares in synthetic DNA manufacturer Twist Bioscience (TWST) on June 30, following earlier sales during the month. Despite concerns about a potential loss of confidence, the move appears to be part of portfolio rebalancing as Ark also invested capital into other companies like Circle Internet Group and SoFi Technologies.
